SOX9 and glioblastoma: The results demonstrated that CMPD1 effectively arrested MDA-MB-231 cells in the G2/M phase at concentrations ranging from 1 to 10 μM (Figure 1B), consistent with previous observations in glioblastoma cells (Gurgis et al., 2015).